Work

Biomarkers, imaging and safety in a well-compensated NASH cirrhotic cohort treated with resmetirom, a thyroid hormone receptor beta agonist, for 52 weeks

Year: 2022

Type: article

Source: Journal of Hepatology

DOI: 10.1016/s0168-8278(22)00567-0

Authors: Stephen Harrison, Kris Kowdley, Rebecca Taub, Naim Alkhouri, Guy Neff

Institutions: Liver Institute Northwest, Madrigal Pharmaceuticals (United States), Arizona Liver Health, Covenant Research and Clinics (United States)

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4283822498

FWCI: 0.181

Cites:

Cited by: 1

Related to: 10